Crestline Management’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,068
Closed -$901K 415
2024
Q4
$901K Buy
+35,068
New +$901K 0.03% 433